Company
Headquarters: Herzliya, Israel
Employees: 23
₪382.1 Million
ILS as of Jan. 1, 2024
US$105.8 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $121.36 B |
| Regeneron Pharmaceuticals, Inc. | $115.11 B |
| CSL Limited | $95.75 B |
| Marinomed Biotech AG | $75.67 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Solegreen Ltd engages in the set-up, development, planning, construction, management, and operation of power generation facilities based on renewable energy in Israel. The company was formerly known as Procognia (Israel) Ltd. and changed its name to Solegreen Ltd in January 2015. Solegreen Ltd was founded in 2000 and is based in Herzliya, Israel.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Solegreen Ltd has the following listings and related stock indices.
Stock: TASE: SLGN wb_incandescent